Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert Kolb

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
The American Journal of Clinical Nutrition|February 26, 2010
Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trialKerstin Kempf, Christian Herder, Iris Erlund, et al.
Diabetes|November 25, 2005
Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4)Christian Herder, Burkhard Haastert, Sylvia Müller-Scholze, et al.
Cytokine|February 7, 2012
Cellular interferon-γ and interleukin-13 immune reactivity in type 1, type 2 and latent autoimmune diabetes: action LADA 6Alexander Strom, Barbara Menart, Marie-Christine Simon, et al.
Cytokine|August 12, 2004
Evaluation of diagnostic relevance of mRNA levels in peripheral blood: predictive value for mortality in hemodialysis patientsReiner Füth, Christian Herder, Stefan Förster, et al.
European Journal of Endocrinology|February 3, 2006
Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4)Christian Herder, Sylvia Müller-Scholze, Philipp Rating, et al.
Diabetes Care|August 31, 2016
Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11Nanette C Schloot, Minh N Pham, Mohammed I Hawa, et al.
Diabetes|December 25, 2003
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001Jerry P Palmer, G Alexander Fleming, Carla J Greenbaum, et al.
Diabetes|July 29, 2006
Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention StudyChristian Herder, Markku Peltonen, Wolfgang Koenig, et al.
Diabetes Care|June 19, 2015
Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of conceptMarie-Christine Simon, Klaus Strassburger, Bettina Nowotny, et al.
The British Journal of Nutrition|December 3, 2011
Dietary factors and low-grade inflammation in relation to overweight and obesityPhilip C Calder, Namanjeet Ahluwalia, Fred Brouns, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
The American Journal of Clinical Nutrition|February 26, 2010
Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trialKerstin Kempf, Christian Herder, Iris Erlund, et al.
Diabetes|November 25, 2005
Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4)Christian Herder, Burkhard Haastert, Sylvia Müller-Scholze, et al.
Cytokine|February 7, 2012
Cellular interferon-γ and interleukin-13 immune reactivity in type 1, type 2 and latent autoimmune diabetes: action LADA 6Alexander Strom, Barbara Menart, Marie-Christine Simon, et al.
Cytokine|August 12, 2004
Evaluation of diagnostic relevance of mRNA levels in peripheral blood: predictive value for mortality in hemodialysis patientsReiner Füth, Christian Herder, Stefan Förster, et al.
European Journal of Endocrinology|February 3, 2006
Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4)Christian Herder, Sylvia Müller-Scholze, Philipp Rating, et al.
Diabetes Care|August 31, 2016
Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11Nanette C Schloot, Minh N Pham, Mohammed I Hawa, et al.
Diabetes|December 25, 2003
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001Jerry P Palmer, G Alexander Fleming, Carla J Greenbaum, et al.
Diabetes|July 29, 2006
Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention StudyChristian Herder, Markku Peltonen, Wolfgang Koenig, et al.
Diabetes Care|June 19, 2015
Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of conceptMarie-Christine Simon, Klaus Strassburger, Bettina Nowotny, et al.
The British Journal of Nutrition|December 3, 2011
Dietary factors and low-grade inflammation in relation to overweight and obesityPhilip C Calder, Namanjeet Ahluwalia, Fred Brouns, et al.
Pageof 9